ʻO ka Liposomal NMN kahi mea olaola e hoʻohui i ka ʻenehana liposome me NMN (niacin mononucleotide). ʻO ka NMN kahi waiwai me nā waiwai anti-kahiko a manaʻoʻiʻo ʻia e hoʻomaikaʻi i ka metabolism ikehu cellular, hoʻonui i ka ikaika o ka cell a pale i nā cell mai ke kaumaha oxidative. ʻO nā liposome nā ʻāpana i haku ʻia me kahi ʻano lipid papalua e like me ka membrane cell, hiki ke kōkua i ka hoʻoheheʻe ʻana a hoʻopaʻa i nā lāʻau lapaʻau, a laila e hoʻomaikaʻi ai i ko lākou bioavailability. ʻO ka hoʻopili ʻana i ka NMN i loko o nā liposomes e hoʻomaikaʻi i ka paʻa a me ka bioavailability o NMN a maʻalahi ia e lawe ʻia e nā cell. Manaʻo ʻia ʻo Liposome NMN e loaʻa i kēia mau mea maikaʻi: E hoʻomaikaʻi i ka maikaʻi o ka absorption: Ma ka hoʻopili ʻana iā ia i loko o nā liposomes, hiki ke hoʻomaikaʻi i ka solubility a me ka paʻa o NMN, a laila e hoʻonui ai i ka pono absorption i loko o nā cell. Hoʻonui i ka bioavailability: Hiki i nā liposome ke kōkua i ka NMN cross cell membranes ʻoi aku ka maikaʻi, e hoʻomaikaʻi i kona bioavailability a e ʻae iā ia e hana pono. Hāʻawi i ka pale: Hiki i nā liposome ke pale aku i ka NMN mai ka pōʻino e ka wai o ka ʻōpū acidic a me nā enzyme digestive ʻē aʻe, ma laila e hoʻonui ai i kona kūpaʻa a me ka bioavailability i loko o ka ʻōpū. Ma keʻano laulā, ʻo ka liposomal NMN kahi mea olaola e hoʻohui i ka ʻenehana liposome a me ka NMN. Ma ka hoʻomaikaʻi ʻana i ke kūpaʻa a me ka bioavailability o NMN, hiki iā ia ke hoʻoikaika maikaʻi i nā waiwai anti-aging o NMN, hoʻoikaika i ke olakino cell a me ka ikaika.
Pono oNMN Pauda
Manaʻo ʻia ʻo Liposome NMN e loaʻa i kēia mau mea maikaʻi: E hoʻomaikaʻi i ka maikaʻi o ka absorption: Ma ka hoʻopili ʻana iā ia i loko o nā liposomes, hiki ke hoʻomaikaʻi i ka solubility a me ka paʻa o NMN, a laila e hoʻonui ai i ka pono absorption i loko o nā cell. Hoʻonui i ka bioavailability: Hiki i nā liposome ke kōkua i ka NMN cross cell membranes ʻoi aku ka maikaʻi, e hoʻomaikaʻi i kona bioavailability a e ʻae iā ia e hana pono. Hāʻawi i ka pale: Hiki i nā liposome ke pale aku i ka NMN mai ka pōʻino e ka wai o ka ʻōpū acidic a me nā enzyme digestive ʻē aʻe, ma laila e hoʻonui ai i kona kūpaʻa a me ka bioavailability i loko o ka ʻōpū. Ma keʻano laulā, ʻo ka liposomal NMN kahi mea olaola e hoʻohui i ka ʻenehana liposome a me ka NMN. Ma ka hoʻomaikaʻi ʻana i ke kūpaʻa a me ka bioavailability o NMN, hiki iā ia ke hoʻoikaika maikaʻi i nā waiwai anti-aging o NMN, hoʻoikaika i ke olakino cell a me ka ikaika.
Nā ʻikamu hoʻāʻo | Nā kikoʻī | Nā ʻano hana |
Nā ho'āʻo o nā mea hana | ||
NMN ʻIke (HPLC) | ≥99.0% | T/CASME 012-2021 |
NMN Maʻemaʻe (HPLC) | 98.00%-101.00% | T/CASME 012-2021 |
Nā ho'āʻo kino | ||
Ka nana aku | Keokeo a keokeo maikai powder | Nānā |
ʻono a ʻala | Skā mākouʻono | Organoleptic |
pH waiwai | 3.0-4.0 | GB 5009.237 |
ʻAno nui | 0.30-0.65g/mL | GB 5009.2 |
ʻAno wai | ≤0.50% | GB 5009.3 |
Lehu ma loko | ≤0.50% | GB 5009.4 |
Ho'āʻo Kemika | ||
Nā Metala Kaumaha | ≤10.00ppm | GB 5009.74 |
ʻO Pb | ≤0.10ppm | GB 5009.12 |
AsArsenic> | ≤0.10ppm | GB 5009.11 |
Cd | ≤0.20ppm | GB 5009.15 |
Hg | ≤0.10ppm | GB 5009.17 |
Potauma | ≤100ppm | GB 5009.91 |
Sinaina | ≤100ppm | GB 5009.91 |
Ke koena solvent(Ethanol) | ≤1,000ppm | GB 5009.262 |
Nā hoʻokolohua Microbiological | ||
Huina BacterialʻO Counts | ≤1,000cfu/g | GB 4789.2 |
Huna a me ka Molds | ≤25cfu/g | GB 4789.15 |
Coliform | 50MPN/100g | GB 4789.3 |
E. Coli | Maikaʻi i ka 1g | GB 4789.38 |
Salmonella | Loaʻa ʻole i ka 10g | GB 4789.4 |
Staphylococcus aureus | Maikaʻi i ka 1g | GB 4789.10 |
Endotoxin bacteria | ≤0.5EU/mg | Mokuna P2020 IV |
* Nā ʻōlelo:Iradiatednoa, GMO noa, Additives manuahi, Allergen Free. |
★ He 800,000㎡ke kumu mahiai ma Inner Monglia.
★ ʻO ka pauka Spirulina a me ka extract i lawe ʻia i nā ʻāina ʻoi aku ma mua o 60.
★ ʻAʻole nā meaʻawaʻawa Microcystic, kūpono nā PAH a me ka ETO Free.
★ Nā huahana maʻamau, ke kumu kūʻai kūpono, hāʻawi mau ʻia ka lawelawe ʻoihana.